Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-25-012238

Chief Financial Officer acquired 76,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gabay Avraham Chief Financial Officer 2025-02-11 Grant or award +34,000 392,040 D
Gabay Avraham Chief Financial Officer 2025-02-11 Grant or award +42,000 434,040 D
Loading xslF345X05/ownership.xml…